GSK plc (LON:GSK) Given Consensus Recommendation of “Moderate Buy” by Brokerages

GSK plc (LON:GSK) has been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is GBX 1,805.83 ($22.63).

GSK has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,850 ($23.18) price target on shares of GSK in a report on Tuesday, September 3rd. JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of GSK in a research report on Wednesday, December 11th. Finally, Berenberg Bank decreased their target price on shares of GSK from GBX 1,820 ($22.81) to GBX 1,600 ($20.05) and set a “buy” rating for the company in a research report on Friday, November 29th.

Insider Activity

In related news, insider Jonathan Symonds acquired 1,500 shares of GSK stock in a transaction on Friday, December 20th. The stock was acquired at an average price of GBX 1,315 ($16.48) per share, for a total transaction of £19,725 ($24,718.05). Over the last three months, insiders have bought 8,658 shares of company stock valued at $11,950,792. Company insiders own 1.61% of the company’s stock.

GSK Trading Up 0.1 %

GSK opened at GBX 1,340.50 ($16.80) on Friday. GSK has a 52 week low of GBX 1,282.50 ($16.07) and a 52 week high of GBX 1,823.50 ($22.85). The company has a market capitalization of £54.69 billion, a P/E ratio of 1,186.28, a PEG ratio of 1.24 and a beta of 0.31. The stock’s fifty day moving average is GBX 1,376.50 and its two-hundred day moving average is GBX 1,499.32. The company has a quick ratio of 0.73, a current ratio of 0.82 and a debt-to-equity ratio of 123.04.

GSK Announces Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, November 14th will be issued a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 1.03%. The ex-dividend date is Thursday, November 14th. GSK’s dividend payout ratio (DPR) is presently 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.